BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.
…
continue reading
1
Steve Uden: Co-Founder and CEO of Rallybio
31:32
31:32
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
31:32
Steve Uden, co-founder and CEO of RallyBio, shares his insights about leadership in biopharma and how Rallybio is working to to profoundly change the odds for patients living with rare diseases.Kirjoittanut Steve Uden
…
continue reading
1
Karine Rossignol: Co-Founder and CEO of Smart Immune
35:56
35:56
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
35:56
Karine Rossignol, co-founder and CEO of Smart Immune, shares her insights with BioBoss host John Simboli about leadership in biopharma and how Smart Immune is working to harness a patient's own thymus to re-arm the immune system against cancer and infection.Kirjoittanut Karine Rossignol
…
continue reading
1
Erik Buntinx: Founder and CEO of ANeuroTech
49:17
49:17
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
49:17
Erik Buntinx, founder and CEO of ANeuroTech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how ANeurotech is working to develop effective treatments, with minimal or no side-effects, for patients who suffer with depressionKirjoittanut Erik Buntinx
…
continue reading
1
Helen Torley: CEO of Halozyme Therapeutics
39:09
39:09
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
39:09
Helen Torley, CEO of Halozyme Therapeutics, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Halozyme is working to reinvent the patient experience by easing the burden of treatment and improving patient outcomes.Kirjoittanut Helen Torley
…
continue reading
1
James Graham: CEO of Recce Pharmaceuticals
21:06
21:06
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
21:06
James Graham, CEO of Recce Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Recce is working to develop a new class of synthetic anti-infectives designed to address the threat of antibiotic-resistant superbugs.Kirjoittanut James Graham
…
continue reading
1
Mike Gaffney: CEO of Cellphire Therapeutics
39:17
39:17
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
39:17
Mike Gaffney, CEO of Cellphire Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Cellphire is working to save lives by bringing novel hemostatic products to patients in need.Kirjoittanut Mike Gaffney
…
continue reading
1
David Baram: Founder and CEO of EmendoBio
35:41
35:41
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
35:41
David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease.Kirjoittanut David Baram
…
continue reading
BioBoss podcast host John Simboli reflects on Seasons 1-5 and invites listeners to Season 6 starting in January 2024Kirjoittanut John Simboli
…
continue reading
1
Anat Binur: Co-Founder and CEO of Ukko
35:42
35:42
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
35:42
Anat Binur, co-founder and CEO of Ukko, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Ukko is working to improve the lives of people who suffer from food allergies.Kirjoittanut Anat Binur
…
continue reading
1
Markku Jalkanen: Founder and CEO of Faron Pharmaceuticals
27:58
27:58
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
27:58
Markku Jalkanen, founder and CEO of Faron Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Faron is working to develop new immunotherapies to address unmet medical needs in cancer and improve patient lives.Kirjoittanut Markku Jalkanen
…
continue reading
1
Lisa Deschamps: CEO of AviadoBio
46:22
46:22
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
46:22
Lisa Deschamps, CEO of AviadoBio, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how AviadoBio is working to develop transformative medicines for patients living with debilitating and life-threatening neurodegenerative disorders.Kirjoittanut Lisa Deschamps
…
continue reading
1
Leonard Mazur: Founder and CEO of Citius Pharma
32:35
32:35
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
32:35
Leonard Mazur, founder and CEO of Citius Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Citius is working to unlock the potential of first-in-class critical care therapeutics, with a pipeline of anti-infectives in oncology, adjunct cancer care and stem cell therapy.…
…
continue reading
1
Dario Neri: Co-Founder and CEO of Philogen
39:13
39:13
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
39:13
Dario Neri, co-founder and CEO of Philogen, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Philogen is working to discover and develop targeted therapies to treat cancer and chronic inflammation.Kirjoittanut Dario Neri
…
continue reading
1
Naseem Amin: CEO of Orphalan
43:47
43:47
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
43:47
Naseem Amin, CEO of Orphalan, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Orphalan is working to transform rare disease treatment.Kirjoittanut Naseem Amin
…
continue reading
1
Hartmut Ehrlich: CEO of Abivax
50:11
50:11
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
50:11
Hartmut Ehrlich, CEO of Abivax, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Abivax is working to develop treatments modulating the body’s natural immune system to treat patients with chronic inflammatory diseases, viral infections and cancer.Kirjoittanut Hartmut Ehrlich
…
continue reading
1
Ivo Timmermans: Co-Founder and CEO of Pleco Therapeutics
41:32
41:32
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
41:32
Ivo Timmermans, co-founder and CEO of Pleco Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Pleco is working to develop breakthrough therapies that change the balance in the treatment of cancer.Kirjoittanut Ivo Timmermans
…
continue reading
1
Philipp Spycher: Co-Founder and CEO of Araris Biotech
39:22
39:22
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
39:22
Philipp Spycher, co-founder and CEO of Araris Biotech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Araris is working to develop a linker technology for antibody-drug conjugates that enables attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.…
…
continue reading
1
Patrick Arensdorf: Founder and CEO of Exai Bio
39:01
39:01
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
39:01
Pat Arensdorf, founder and CEO of Exai Bio, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Exai is working to develop a next-generation RNA-based platform to deliver actionable insight into cancer biology from a simple blood draw.Kirjoittanut Patrick Arensdorf
…
continue reading
1
Josh Geballe: Managing Director of Yale Ventures
34:27
34:27
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
34:27
Josh Geballe, Managing Director of Yale Ventures, shares his thoughts with BioBoss host John Simboli about leadership and community building in biopharma. Yale Ventures is a new initiative created by Yale University to support and expand innovation and entrepreneurship across Yale university and throughout the greater New Haven region with the goal…
…
continue reading
BioBoss podcast host John Simboli reflects on the success of seasons 1, 2 ,3 and 4 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss season 5. John is delighted to open BioBoss season 5 with his conversation with Josh Geballe, Managing Director of Yale Ventures, who shares his thou…
…
continue reading
1
Luca Benatti: CEO of EryDel
41:31
41:31
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
41:31
Luca Benatti, CEO of EryDel, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how EryDel is working to develop specialized therapies for the treatment of rare diseases by using the patient’s own blood.Kirjoittanut Luca Benatti
…
continue reading
1
Elisabet de los Pinos: Founder and CEO of Aura Biosciences
35:05
35:05
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
35:05
Elisabet de los Pinos, founder and CEO of Aura Biosciences, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Aura is working to envision new ways to treat cancer.Kirjoittanut Elisabet de los Pinos
…
continue reading
1
Paul Radspinner: Founder and CEO of Flugen
46:00
46:00
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
46:00
Paul Radspinner, founder and CEO of Flugen, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Flugen is working to develop a more effective vaccine in the fight against influenza and respiratory disease.Kirjoittanut Paul Radspinner
…
continue reading
1
Jesús Martin-Garcia: CEO of GeNeuro
42:01
42:01
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
42:01
Jesús Martin-Garcia, CEO of GeNeuro, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Geneuro is working to develop treatments against neurological disorders and autoimmune diseases by neutralizing causal factors encoded by Human Endogenous Retroviruses.Kirjoittanut Jesús Martin-Garcia
…
continue reading
1
Cliff Stocks: Founder and CEO of OncoResponse
34:25
34:25
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
34:25
Cliff Stocks, founder and CEO of OncoResponse speaks with BioBoss host John Simboli. Hear Cliff’s insights about leadership in biopharma and how OncoResponse is working to identify fully human monoclonal antibodies as therapeutics for the treatment of cancer.Kirjoittanut Cliff Stocks
…
continue reading
1
Brian Finrow: Co-Founder and CEO of Lumen Bioscience
41:08
41:08
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
41:08
Brian Finrow, Co-founder and CEO of Lumen Bioscience, speaks with BioBoss host and biopharma branding veteran John Simboli. Hear Brian’s thoughts about leadership and how Lumen Biosciences is working to unlock the full potential of biologic drugs, whose promise has been held back by the lack of scalable technology.…
…
continue reading
1
Alex Blyth: Founder and CEO of LifT BioSciences
36:36
36:36
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
36:36
BioBoss host John Simboli speaks with Alex Blyth, founder and CEO of LifT BioSciences.Kirjoittanut Alex Blyth
…
continue reading
1
Andrew Hall: CEO of IMV Inc.
30:23
30:23
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
30:23
Hear Andrew speak with BioBoss host John Simboli about leadership in biopharma and how IMV is working on advancing a portfolio of therapies based on the Company’s immune-educating platform.Kirjoittanut Andrew Hall
…
continue reading
1
Kevin Lee: CEO of Bicycle Biotherapeutics
39:47
39:47
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
39:47
Kevin Lee, CEO of Bicycle Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Bicycle Therapeutics is working on developing a new class of medicines, called Bicycles, for diseases that are underserved by existing therapeutics.Kirjoittanut Kevin Lee
…
continue reading
1
Reenie McCarthy: CEO of Stealth BioTherapeutics
27:05
27:05
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
27:05
BioBoss host John Simboli speaks with Reenie McCarthy, CEO of Stealth BioTherapeutics, headquartered in Needham, MA.. Hear Reenie's thoughts about leadership in biopharma and how Stealth Biotherapeutics is working on developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-relate…
…
continue reading
1
Yochi Slonim: Founder and CEO of Anima Biotech
40:43
40:43
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
40:43
BioBoss host John Simboli speaks with Yochi Slonim, founder and CEO of Anima Biotech, headquartered in Boston with R&D in Tel Aviv.. Hear Yochi's thoughts about leadership in biopharma and how Anima Biotech is working on a novel approach for the discovery of small molecules that selectively control mRNA translation as a new strategy against undrugg…
…
continue reading
1
Clive Richardson: CEO of Akari Therapeutics
32:36
32:36
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
32:36
BioBoss host John Simboli speaks with Clive Richardson, CEO of Akari Therapeutics, headquartered in London with offices in New York. Hear Clive's thoughts about leadership in biopharma and how Akari Therapeutics is working to develop life-transforming treatments for autoinflammatory diseases involving the complement and leukotriene pathways…
…
continue reading
BioBoss podcast host John Simboli reflects on the success of seasons 1, 2 and 3 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss season 4.Kirjoittanut John Simboli
…
continue reading
1
Stefan König: CEO of George Medicines
38:06
38:06
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
38:06
BioBoss host John Simboli speaks with Stefan König , CEO of George Medicines, headquartered in London. Hear Stefan’s thoughts about leadership in biopharma and how George Medicines is working to extend and improve the lives of people suffering from the world’s leading causes of death and disability—including hypertension, cardiovascular disease and…
…
continue reading
1
Derek Maetzold: CEO of Castle Biosciences
38:12
38:12
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
38:12
Derek Maetzold, CEO of Castle Biosciences shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Castle is leveraging its expertise in cancer genomics and the use of artificial intelligence to improve patient outcomes.Kirjoittanut Derek Maetzold
…
continue reading
1
Bob Cobuzzi: CEO of Diffusion Pharmaceuticals
34:22
34:22
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
34:22
Bob Cobuzzi, Chief Executive Officer of Diffusion Pharmaceuticals,speaks with BioBoss John Simboli about leadership and how Diffusion Pharmaceuticals is working to develop novel therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed most.Kirjoittanut Bob Cobuzzi
…
continue reading
1
Panna Sharma: CEO of Lantern Therapeutics
38:38
38:38
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
38:38
Panna Sharma, CEO of Lantern Pharma, headquartered in Dallas, Texas, shares his thoughts with BioBoss host John Simboli about leadership and how Lantern is working at the intersection of artificial intelligence, genomics and machine learning to advance precision oncology therapies.Kirjoittanut Panna Sharma
…
continue reading
1
Nandan Padukone: CEO of IM Therapeutics
44:36
44:36
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
44:36
Nandan Padukone, CEO of IM Therapeutics, headquartered in Woburn, Massachusetts, shares his thoughts with BioBoss host John Simboli about leadership and how IM Therapeutics is targeting the root cause of autoimmunity with therapeutic design directed at human leukocyte antigens.Kirjoittanut Nandan Padukone
…
continue reading
1
Matthew Gline: CEO of Roivant Sciences
39:20
39:20
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
39:20
"I think I've always found motivation from being able to take a highly technical topic and dig in. I'm never the person that knows most about the topic. But I strive to be like the person who knows third or fourth most about whatever topic is going." – Mathew Gline: CEO of Roivant SciencesKirjoittanut Matthew Gline
…
continue reading
1
Koen De Witte: Managing Director of ReMYND
31:19
31:19
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
31:19
Koen De Witte, managing director of reMYND NV, headquartered in Leuven, Belgium, shares his thoughts with BioBoss host John Simboli about leadership and how reMYND is advancing treatments for Alzheimer’s, diabetes and other diseases caused by cellular dysfunction.Kirjoittanut Koen De Witte
…
continue reading
1
Lanny Sun: Co-founder of Silicon Therapeutics
36:43
36:43
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
36:43
Lanny Sun, co-founder of Silicon Therapeutics, recently acquired by Roivant Sciences. speaks with corporate branding veteran John Simboli about leadership in biopharma. Lanny also discusses how Silicon Therapeutics, now part of Roivant Drug Discovery, is advancing its chip-to-clinic, computational quantum physics-based approach to pioneer a new pat…
…
continue reading
1
Joan Perelló: Co-Founder and CEO of Sanifit
36:43
36:43
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
36:43
Joan Perelló, co-founder and CEO of Sanifit, shares his thoughts with BioBoss host John Simboli about leadership and how Sanifit is pursuing the development of treatments for progressive vascular calcification disorders.Kirjoittanut Joan Perelló
…
continue reading
1
Saiid Zarrabian: CEO of Kintara Therapeutics
27:15
27:15
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
27:15
Saiid Zarrabian, President and CEO of Kintara Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership and how Kintara is pursuing the development of new cancer therapies for patients with rare unmet medical needs.Kirjoittanut Saiid Zarrabian
…
continue reading
1
John Temperato: CEO of 9 Meters Biopharma
32:05
32:05
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
32:05
John Temperato, President and Chief Executive Officer of 9 Meters Biopharma, speaks with BioBoss host John Simboli about leadership in biopharma and how 9 Meters is advancing drug candidates for patients with rare and unmet gastrointestinal disorders including short bowel syndrome and celiac disease.…
…
continue reading
1
Shawn Singh: CEO of VistaGen Therapeutics
39:58
39:58
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
39:58
Shawn Singh, CEO of VistaGen, speaks with BioBoss host John Simboli about leadership and VistaGen's working to develop a new generation of medications for anxiety, depression and other central nervous system disorders.Kirjoittanut Shawn Singh
…
continue reading
BioBoss podcast host John Simboli reflects on the success of seasons 1 and 2 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss season 3.Kirjoittanut John Simboli
…
continue reading
1
Bobby Gaspar: CEO of Orchard Therapeutics
40:09
40:09
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
40:09
Bobby Gaspar, founder and CEO of Orchard Therapeutics, speaks with BioBoss host John Simboli about leadership and how Orchard Therapeutics is pursuing the opportunity to change medicine and change the lives of people with severe genetic diseases.Kirjoittanut Bobby Gaspar
…
continue reading
1
Itamar Kandel: CEO of HeartVista
37:14
37:14
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
37:14
Itamar Kandel, CEO of HeartVista, speaks with BioBoss host John Simboli about leadership and how HeartVista leverages machine learning to simplify diagnostic imaging and help physicians more accurately diagnose cardiovascular disease.Kirjoittanut Itamar Kandel
…
continue reading
1
Mark Altmeyer: Founder and CEO of Arvelle Therapeutics
33:37
33:37
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
33:37
Mark Altmeyer, founder and CEO of Arvelle Therapeutics, speaks with BioBoss host John Simboli. Hear Mark’s thoughts about leadership and how Arvelle is working to bring new solutions to people living with epilepsy and CNS disorders.Kirjoittanut Mark Altmeyer
…
continue reading
1
Jacob Becraft: Co-Founder and CEO of Strand Therapeutics
44:52
44:52
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
44:52
Jacob Becraft, co-founder & CEO of Strand Therapeutics shares his thoughts with BioBoss host John Simboli about leadership and how Strand is working in synthetic biology and messenger RNA to target root causes of genetic disease, with the power to control editing at a single-cell level.Kirjoittanut Jacob Becraft
…
continue reading